Andreas Asimakos
National and Kapodistrian University of Athens
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andreas Asimakos.
Journal of Applied Physiology | 2015
Eleni Kortianou; Andrea Aliverti; Zafeiris Louvaris; Maroula Vasilopoulou; Ioannis Nasis; Andreas Asimakos; Spyros Zakynthinos; Ioannis Vogiatzis
In patients with chronic obstructive pulmonary disease (COPD), reduced levels of daily physical activity are associated with the degree of impairment in lung, peripheral muscle, and central hemodynamic function. There is, however, limited evidence as to whether limitations in tidal volume expansion also, importantly, determine daily physical activity levels in COPD. Eighteen consecutive patients with COPD [9 active (forced expiratory volume in 1 s, FEV1: 1.59 ± 0.64 l) with an average daily movement intensity >1.88 m/s(2) and 9 less active patients (FEV1: 1.16 ± 0.41 l) with an average intensity <1.88 m/s(2)] underwent a 4-min treadmill test at a constant speed corresponding to each individual patients average movement intensity, captured by a triaxial accelerometer during a preceding 7-day period. When chest wall volumes, captured by optoelectronic plethysmography, were expressed relative to comparable levels of minute ventilation (ranging between 14.5 ± 4.3 to 33.5 ± 4.4 l/min), active patients differed from the less active ones in terms of the lower increase in end-expiratory chest wall volume (by 0.15 ± 0.17 vs. 0.45 ± 0.21 l), the greater expansion in tidal volume (by 1.76 ± 0.58 vs. 1.36 ± 0.24 l), and the larger inspiratory reserve chest wall volume (IRVcw: by 0.81 ± 0.25 vs. 0.39 ± 0.27 l). IRVcw (r(2) = 0.420), expiratory flow (r(2) change = 0.174), and Borg dyspnea score (r(2) change = 0.123) emerged as the best contributors, accounting for 71.7% of the explained variance in daily movement intensity. Patients with COPD exhibiting greater ability to expand tidal volume and to maintain adequate inspiratory reserve volume tend to be more physically active. Thus interventions aiming at mitigating restrictions on operational chest wall volumes are expected to enhance daily physical activity levels in COPD.
Respiratory Physiology & Neurobiology | 2017
Zafeiris Louvaris; Helmut Habazettl; Andreas Asimakos; Harrieth Wagner; Spyros Zakynthinos; Peter D. Wagner; Ioannis Vogiatzis
The study investigated whether the capacity to regulate muscle blood flow (Q) relative to metabolic demand (VO2) is impaired in COPD. Using six NIRS optodes over the upper, middle and lower vastus lateralis in 6 patients, (FEV1:46±12%predicted) we recorded from each: a) Q by indocyanine green dye injection, b) VO2/Q ratios based on fractional tissue O2 saturation and c) VO2 as their product, during constant-load exercise (at 20%, 50% and 80% of peak capacity) in normoxia and hyperoxia (FIO2:1.0). At 50 and 80%, relative dispersion (RD) for Q, but not for VO2, was greater in normoxia (0.67±0.07 and 0.79±0.08, respectively) compared to hyperoxia (0.57±0.12 and 0.72±0.07, respectively). In both conditions, RD for VO2 and Q significantly increased throughout exercise; however, RD of VO2/Q ratio was minimal (normoxia: 0.12-0.08 vs hyperoxia: 0.13-0.09). Muscle Q and VO2 appear closely matched in COPD patients, indicating a minimal impact of heterogeneity on muscle oxygen availability at submaximal levels of exercise.
International Journal of Chronic Obstructive Pulmonary Disease | 2018
Andreas Asimakos; Dimitrios Toumpanakis; Maria-Helena Karatza; Spyridoula Vasileiou; Paraskevi Katsaounou; Zafeiria Mastora; Theodoros P. Vassilakopoulos
Background/hypothesis Whole body exercise (WBE) changes lymphocyte subset percentages in peripheral blood. Resistive breathing, a hallmark of diseases of airway obstruction, is a form of exercise for the inspiratory muscles. Strenuous muscle contractions induce oxidative stress that may mediate immune alterations following exercise. We hypothesized that inspiratory resistive breathing (IRB) alters peripheral blood lymphocyte subsets and that oxidative stress mediates lymphocyte subpopulation alterations following both WBE and IRB. Patients and methods Six healthy nonathletes performed two WBE and two IRB sessions for 45 minutes at 70% of VO2 maximum and 70% of maximum inspiratory pressure (Pimax), respectively, before and after the administration of antioxidants (vitamins E, A, and C for 75 days, allopurinol for 30 days, and N-acetylcysteine for 3 days). Blood was drawn at baseline, at the end of each session, and 2 hours into recovery. Lymphocyte subsets were determined by flow cytometry. Results Before antioxidant supplementation at both WBE end and IRB end, the natural killer cell percentage increased, the T helper cell (CD3+ CD4+) percentage was reduced, and the CD4/CD8 ratio was depressed, a response which was abolished by antioxidants only after IRB. Furthermore, at IRB end, antioxidants promoted CD8+ CD38+ and blunted cytotoxic T-cell percentage increase. CD8+ CD45RA+ cell percentage changes were blunted after antioxidant supplementation in both WBE and IRB. Conclusion We conclude that IRB produces (as WBE) changes in peripheral blood lymphocyte subsets and that oxidative stress is a major stimulus predominantly for IRB-induced lymphocyte subset alterations.
Tobacco Induced Diseases | 2014
Eleni Ischaki; Eleni Litsiou; Vasiliki Saltagianni; Ioanna Nikoloutsou; Aikaterini Tsoutsa; Andreas Asimakos; Spyros Zakynthinos; Paraskevi Katsaounou
Background Many patients with mild–moderate COPD (chronic obstructive pulmonary disease), are asymptomatic. Since expressed symptoms are usually mild and mostly attributed to age, they are often underestimated [1,2]. Thus early COPD patients usually remain undiagnosed [3]. The aim of the study is to evaluate the rates of undiagnosed COPD cases in early stages of the disease (stage I and II according to GOLD classification), [4] in our smoking cessation program and to assess the effectiveness of COPD diagnosis as a motivational tool for quitting smoking.
European Respiratory Journal | 2014
Eleni Ischaki; Eleni Litsiou; Vassiliki Saltagianni; Filipos Filippidis; Aikaterini Tsoutsa; Ioanna Nikoloutsou; Andreas Asimakos; Spyridon Zakynthinos; Paraskevi Katsaounou
European Respiratory Journal | 2017
Zafeiris Louvaris; Nikolaos Chynkiamis; Nikolaos Anastasopoulos; Zoe Mavrofrida; Stavroula Spetsioti; Andreas Asimakos; Spyros Zakynthinos; Ioannis Vogiatzis
Archive | 2015
Darren S. DeLorey; John M. Kowalchuk; Donald H. Paterson; Braden M. R. Gravelle; Juan M. Murias; Matthew D. Spencer; M John; Andreas Asimakos; Spyros Zakynthinos; Ioannis Vogiatzis; Zafeiris Louvaris; Eleni Kortianou; Stavroula Spetsioti; Maroula Vasilopoulou; Ioannis Nasis
Archive | 2015
Manuel G. Cosio; Ioanna Dimopoulou; Richard Finkelstein; H. Schulz; R. Ewert; C. Schäper; S. Gläser; T. Ittermann; B. Koch; H. Völzke; H. Wallaschofski; M. Nauck; C. Warnke; Kevin E. Finucane; Bhajan Singh; Andreas Asimakos; Spyros Zakynthinos; Ioannis Vogiatzis; Eleni Kortianou; Andrea Aliverti; Zafeiris Louvaris; Maroula Vasilopoulou; Ioannis Nasis
Archive | 2015
T. Macklem; Antonio Pedotti; Roberto Duranti; Giorgio Scano; Pawel Sliwinski; Sheng Yan; Andrea Aliverti; Bengt Kayser; Stephen J. Cala; Bryan J. Taylor; Stephen C. How; Lee M. Romer; Andreas Asimakos; Spyros Zakynthinos; Ioannis Vogiatzis; Eleni Kortianou; Zafeiris Louvaris; Maroula Vasilopoulou; Ioannis Nasis
Journal of Applied Physiology | 2015
Eleni Kortianou; Andrea Aliverti; Zafeiris Louvaris; Maroula Vasilopoulou; Ioannis Nasis; Andreas Asimakos; Spyros Zakynthinos; Ioannis Vogiatzis